Revenue Growth in Key Segments
Teleflex reported revenues of $764.4 million, up 2.4% year-over-year on a GAAP basis and 2.2% on an adjusted constant currency basis. Interventional revenue increased 11.4% year-over-year, and Vascular Access revenue increased 6.3% year-over-year.
Palette Life Sciences Acquisition Performance
The acquisition of Palette Life Sciences is ahead of expectations, with strong revenue momentum from Barrigel. 2024 revenue guidance for Palette has been increased to $73 million to $75 million.
Gross Margin Improvement
The adjusted gross margin was 60.8% for the quarter, a 140 basis point increase versus the prior year, due to favorable impacts from the termination of the MSA and the acquisition of Palette.
Strong Cash Flow
Cash flow from operations for the first nine months was $435.6 million, a $63.2 million increase from the prior year, driven by favorable operating results and decreased cash outflows from inventories.
Expansion of Clinical Data for Titan SGS Stapler
The Titan SGS Stapler showed significant procedural efficiency and enhanced clinical outcomes in a recent study, supporting its use in laparoscopic sleeve gastrectomy.